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The present study investigated the transcriptomic response of porcine dendritic cells (DC)
to innate stimulation in vitro and in vivo. The aim was to identify DC subset-specialization,
suitable Toll-like receptor (TLR) ligands targeting plasmacytoid DC (pDC), and the DC
activation profile during highly and low virulent classical swine fever virus (CSFV, strain
Eystrup and Pinar del Rio, respectively) infection, chosen as model for a virus causing
a severe immunopathology. After identification of porcine conventional DC (cDC) 1,
cDC2, pDC and a monocyte-derived subset in lymphoid tissues, we characterized DC
activation using transcriptomics, and focused on chemokines, interferons, cytokines,
as well as on co-stimulatory and inhibitory molecules. We demonstrate that porcine
pDC provide important signals for Th1 and interferon responses, with CpG triggering
the strongest responses in pDC. DC isolated early after infection of pigs with either
of the two CSFV strains showed prominent upregulation of CCL5, CXCL9, CXCL10,
CXCL11, and XCL1, as well as of the cytokines TNFSF13B, IL6, IL7, IL12B, IL15,
IL27. Transcription of IL12B and many interferon genes were mostly restricted to pDC.
Interestingly, the infection was associated with a prominent induction of inhibitory and cell
death receptors. When comparing low and highly virulent CSFV strains, the latter induced
a stronger inflammatory and antiviral response but a weaker cell cycle response, and
reduced antigen presentation functions of DC. Taken together, we provide high-resolution
information on DC activation in pigs, as well as information on how DC modulation could
be linked to CSFV immunopathology.
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INTRODUCTION
Dendritic cells (DC) are sentinel innate immune cells that are present in the skin and at mucosal
surfaces and are specialized in the early sensing of pathogens. Antigen uptake by DC, and their
activation-induced migration to secondary lymphoid organs is vital for the initiation of specific
T-cell responses.
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DC can be divided into functionally specialized subsets,
including two conventional DC subsets (cDC1 and cDC2) and
plasmacytoid (p)DC. These subsets not only differ in their ability
to induce particular T-cell responses but also in their expression
of pattern recognition receptors (PRRs) which sense danger
signals such as pathogen- and damage-associated molecular
patterns (1). Triggering of these receptors leads to activation
and maturation of DC, which is associated with a shift in their
expression of chemokine receptors from CCR2 and/or CCR5 to
CCR7, allowing them to migrate toward lymph nodes (LN) (2).
This maturation process is also associated with an upregulation
of costimulatory molecules, which are required for activation of
naïve T cells. Depending on the stimuli and the immunological
environment, signals from activated DC also shape the adaptive
immune response toward Th1, Th2, or Th17 responses.
Importantly, the DC subset-specific expression of PRRs
belonging to the Toll-like receptor (TLR) and C-type lectin
receptor (CLR) family can vary in a species-dependent manner.
In a previous work we identified and precisely characterized
different porcine DC and monocytic cell subsets circulating in
blood, and described some peculiarities of the porcine immune
system (3). These data showed for example that porcine pDC
express the highest levels of TLR7 and TLR9, as observed in
mouse and human, but surprisingly also of TLR3, a PRR mainly
found on cDC1 in both mouse and human (4, 5). Another
example is the high level of TLR9 expression in cDC1 of pigs
but not humans (3). In addition to differences in PRR expression,
our data also indicated functional differences in the response of
porcine DC subsets and monocytes to stimulation. Following in
vitro stimulation of several porcine DC subsets with TLR3, TLR7,
or TLR9 ligands, pDC were the main producers of TNF, IFN-
α, and IL-12p40 and were the only subset to express IL-12p35,
suggesting pDC to be the main source of inflammatory cytokines
and IL-12 in the pig. Surprisingly, pDC were also found to be
responsive to a TLR2 ligand, and even to a TLR4 ligand in terms
of TNF production, again an observation not found with human
pDC. Furthermore, the upregulation of costimulatory molecules
and CCR7 on cDC was often dependent on the presence of pDC
in the cultures (3, 6). This would indicate that in the pig, pDC play
a particularly pivotal role in sensing viruses through TLR3, TLR7,
and TLR9 and in sensing other microbial organisms through cell
surface TLR, resulting in cytokine production and in support for
cDC activation.
Considering the central immunological importance of this
concept, the goal of this study was to follow up on our
previous work and to employ RNA-sequencing (RNA-Seq)-
based transcriptomics to characterize in more detail the immune
response profile of sorted blood DC subsets following in vitro
TLR stimulation. Because of important species differences in
the functional specialization of DC subsets described above, our
main aim was to dissect subset-dependent differences in the
expression of co-stimulatory molecules, and the expression of
cytokines and chemokines as well as their receptors. To this end,
we investigated the transcriptional response of cDC1, cDC2, pDC
and monocytes to a TLR1/2 ligand, known to directly activate
all porcine DC subsets (3). Considering the apparent important
role of pDC in pathogen sensing in the pig, we additionally
investigated the activation profile of pDC following stimulation
with TLR3, TLR7, TLR7/8, or TLR9 ligands. In view of the fact
that in vitro stimulation of isolated DC might not necessarily
reflect the in vivo situation, these data were complemented
with in vivo results obtained during classical swine fever virus
(CSFV) infection. Before doing so, we characterized cDC1,
cDC2, pDC and monocytic cells in lymph nodes and tonsils at
homeostasis by flow cytometry and RNA-Seq. Having achieved a
clear identification of the above-mentioned subsets in secondary
lymphoid organs, we characterized their transcriptomic profiles
following infection with the highly virulent CSFV strain Eystrup
(vEy-37) (7) and the low virulent Pinar del Rio (PdR) strain
(8). We chose CSFV as a model because of the extensive
knowledge on CSFV interaction with the innate immune system
and the strong immunopathological effect of this infection (9). In
fact, infection of pigs is associated with strong innate immune
responses, which includes both an inflammatory cytokine and
interferon type I response that appears to be associated with
a severe depletion of lymphocytes in primary and secondary
lymphoid tissue (9–11). As this response is known to correlate
with the virulence of the CSFV strain (12), we decided to compare
a low and a highly virulent strain of CSFV. Altogether, this work
represents an important step in understanding the functional
specialization of DC subsets in the pig.
MATERIALS AND METHODS
Isolation of Peripheral Blood Mononuclear
Cells, and Cells From Lymph Nodes and
Tonsils
For the in vitro stimulation experiments, blood sampling was
performed on three 14- to 18-months old Large White pigs kept
under specific pathogen-free (SPF) conditions at the Institute
of Virology and Immunology (IVI, Mittelhäusern, Switzerland).
These studies were performed under the licenses BE88/14 and
BE131/17, which were reviewed by the cantonal committee
on animal experiments of the canton of Bern, Switzerland,
and approved by the cantonal veterinary authority (Amt für
Landwirtschaft und Natur LANAT, Veterinärdienst VeD, Bern,
Switzerland). PBMC were isolated by centrifugation on a Ficoll-
paque density gradient (1.077 g/L, GE Healthcare. Chicago, IL,
USA). For the isolation and characterization of DC subsets from
lymph nodes and tonsils, mandibular and retropharyngeal lymph
nodes and tonsils were obtained from SPF pigs slaughtered at
the IVI (Animal facility license BE-VTH-3/14). The pigs were
not slaughtered for the purpose of organ collection. Consent
for collecting samples after slaughter was obtained from the
animal facility manager and the animal welfare officer of the
IVI. Harvested organs were washed with sterile PBS, cut in small
pieces (≈ 0.3 cm3), and incubated in 20mL of DMEM with
Glutamax (Thermofisher, Waltham MA, USA) supplemented
with 10% fetal bovine serum (FBS; Sigma-Aldrich, Buchs,
Switzerland) containing 1 mg/mL collagenase D (Sigma-Aldrich)
and 100µg/mL DNase I (Sigma-Aldrich) during 15min under
agitation at 37◦C. The enzymatic reaction was stopped by adding
2mL of PBS with 5mM EDTA solution. The cells were then
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filtered through a 100µm filter (BD Biosciences, Allschwil,
Switzerland), washed two times with PBS (4◦C) and finally frozen
in liquid nitrogen at 107 cells/mL in freezing medium consisting
of DMEM with 40% FBS and 10% DMSO until further use.
Flow Cytometry and Cell Sorting
The flow cytometry panels used to define DC subsets
and monocytic cells in blood and lymphoid tissues
were based on our previous work defining cDC1 as
CD135+CD14−CD172a−/lowCADM1+wCD11R1+, cDC2 as
CD135+CD14−CD172a+CADM1+CD115+wCD11R1+CD1+,
pDC as CD135+CD14−CD4+CD172a+CD123+CD303+ and
monocytes as CD135−CD14+CD172ahigh (3). The basic staining
protocol employed was a four-step five-color staining described
previously (3). Briefly, cells were incubated with primary
antibodies including anti-CD172a (clone 77-22-15A, kindly
given by Dr. Armin Saalmüller, Veterinary University of Vienna,
Austria) and anti-SynCAM (TSLC1/CADM1) (cross-reactive
anti-mouse Syn-CAM mAb, clone 3E1, MBL International,
Woburn, MA, USA), followed by a second incubation step with
the corresponding secondary antibodies anti-mouse IgG2b Alexa
Fluor 647 (Thermofisher) and anti-chicken IgY biotin (Jackson
Immunoresearch Laboratories, West Grove, PA, USA). After
a third step of Ig blocking (ChromPure mouse IgG 100 ng/ml;
Jackson Immunoresearch), cells were finally incubated with
directly conjugated antibodies anti-CD14-FITC (clone MIL2,
Bio-Rad AbD Serotec, Oxford, UK) and anti-CD4-PerCP-Cy5.5
(clone 74-12-4, BD Biosciences), and with V500-coupled
streptavidin (BD Biosciences). The cell-surface expression of
several markers was determined to further characterize the DC
subsets using the following antibodies: anti-wCD11R1 (clone
MIL4, Bio-Rad), anti-CD1 (clone 76-7-4, kindly provided by
Dr. Armin Saalmüller), anti-CD115 (CSF-1R, clone ROS8G11-
1, kindly provided by Dr. David Hume, Roslin Institute,
University of Edinburgh, UK), anti-CD205 (clone ZH9F7, kindly
provided by Dr. Jesus Hernandez, Centro de Investigación en
Alimentación y Desarrollo, Hermosillo, Mexico) (13), anti-
CD207 (cross-reactive anti-mouse langerin, clone DDX0368,
Dendritics, Lyon, France), anti-MHC II (SLA-DQ, clone TH16B,
Washington State University Monoclonal Antibody Center,
WA, USA), human CD152-mu Ig (human CTLA fusion protein
recognizing CD80/86, Ancell Corporation, Stillwater, MN,
USA), or His-tagged porcine recombinant protein IL-3 or Flt3L
(14, 15). The secondary antibodies used were anti-mouse IgG1-
RPE, anti-mouse IgG2a-RPE (SouthernBiotech, Birmingham,
AL, USA) or anti-His-RPE (Miltenyi Biotec, Bergisch Gladbach,
Germany). For each marker, a “fluorescence minus one” (FMO)
control was included. Acquisition of the samples was performed
on a FACS Canto II (BD Biosciences), using the DIVA software
and the Flowjo software (BD Biosciences) for analysis.
For sorting we employed freshly isolated PBMCs or defrosted
lymph node and tonsil cells as previously described (3). First,
T cells were depleted using the MACS system (Miltenyi Biotec)
on an LD column after incubation with anti-CD3 (hybridoma
clone PPT3/FyH2, kindly given by Dr. K. Haverson, University
of Bristol, UK) and anti-mouse IgG magnetic beads (Miltenyi
Biotec). The CD3-depleted fraction was then stained with anti-
CD172a, anti-CADM1, anti-CD14 and anti-CD4 as described
above, with the exception of V500-conjugated streptavidin which
was replaced by streptavidin coupled to Alexa Fluor 750-APC
(Thermofisher). Sorting of cDC1, cDC2, pDC and monocytes
(for PBMCs) or CD14high cells (for lymph nodes and tonsils)
was performed using a FACS Aria (BD Bioscience) and the
DIVA software.
In vitro Stimulation of Sorted Blood
Mononuclear Phagocytes With TLR
Ligands
Following sorting, blood cDC1, cDC2, pDC and monocytes were
plated in 96-well plates (Corning) at 5 × 104 cells/well in 100
µL of DMEM supplemented with 10% FBS, 1% non-essential
amino acids, 1% sodium pyruvate, 1% HEPES and 20µM
2-mercapthoethanol (all Thermofisher, Gibco). cDC1, cDC2 and
monocytes, were stimulated with 10µg/ml PAM3Cys-SKKKK
(PAM3Cys L2000, EMC microcollections, Tübingen Germany)
or left unstimulated as a control, while pDC were stimulated with
10µg/ml PAM3Cys, 10µg/ml polyinosinic-polycytidytic acid
(poly I:C, Sigma-Aldrich), 5µg/ml gardiquimod (InvivoGen,
San Diego, CA, USA), 5µg/mL resiquimod (Sigma-Aldrich),
or 5µg/ml CpG oligodeoxynucleotide (CpG, sequence
D32, ggTGCGTCGACGCAGggggg, Eurofins Genomics,
Konstanz, Germany) or left unstimulated (controls). After
3 h of stimulation, cells were resuspended in 900 µL TRIzol
(Thermofisher) and kept at−70◦C until mRNA extraction.
Collection and Processing of Lymph Nodes
and Tonsils From Pigs Experimentally
Infected With Classical Swine Fever Virus
The studies in pigs were performed in compliance with the
Animal Welfare Act (TSchG SR 455), the Animal Welfare
Ordinance (TSchV SR 455.1), and the Animal Experimentation
Ordinance (TVV SR 455.163) of Switzerland, under license
BE105/15. All experiments were reviewed by the cantonal
committee on animal experiments of the canton of Bern
and approved by the cantonal veterinary authority (Amt für
Landwirtschaft und Natur LANAT, Veterinärdienst VeD, Bern,
Switzerland). Fifteen 10-week-old Large White pigs, raised at the
institute under SPF conditions, were used for this experiment.
The fifteen animals, including both males and females, were
assigned randomly to three experimental groups: two groups of
six animals to be infected with CSFV, and one mock control
group of three animals. Two CSFV genotype 1 strains differing
in virulence were used for infection: the highly virulent CSFV
strain vEy-37 (7), and the low virulent Pinar del Rio strain
(8). The CSFV strain vEy-37 was prepared from PEDSV.15
cells transfected with transcripts from the cDNA clone pEy-
37 as described elsewhere (16). The CSFV strain Pinar del Rio
was propagated on PEDSV.15 cells using virus-positive serum
collected 4 weeks post-infection from a persistently infected
piglet (piglet #7) (17). In order to remove any soluble factors from
the virus stocks, the PEDSV.15 CSFV extracts were purified by
ultracentrifugation at 70,000 × g for 4 h through a 10% sucrose
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cushion and the pellets were resuspended inMEM. The six pigs of
the two infection groups were then inoculated intranasally with
106 TCID50/pig of purified vEy-37 or Pinar del Rio in 5mLMEM.
The 3 pigs of the control group were administered 5mL MEM
intranasally. At 18 h post-infection, three animals from each
infected group were euthanized and tonsils were harvested. At
42 h post-infection, the remaining three pigs of each group were
euthanized, and mandibular and retropharyngeal lymph nodes
were harvested. Tonsils and mandibular and retropharyngeal
lymph nodes from the three control animals were harvested the
day after. Lymph nodes and tonsils were processed as described
above. Cells were then frozen in liquid nitrogen at 107 cells/mL
in freezing medium until further use. After thawing, cells were
sorted by flow cytometry as described above and harvested in
TRIzol to perform mRNA sequencing on the cDC1, cDC2, pDC,
and CD14high subsets of both control and infected animals.
TRIzol samples were kept at−70◦C until further use.
RNA-Seq and Bioinformatic Processing
For RNA-Seq, mRNAwas extracted from TRIzol lysates of FACS-
sorted cDC1, cDC2, pDC and monocyte or CD14high subsets
from PBMC, lymph nodes and tonsils using the Nucleospin RNA
kit (Macherey Nagel, Düren, Germany) with a modified protocol
as described previously (3). Briefly, 0.2mL chloroform was added
to 1mL of thawed TRIzol lysate, and after vigorous shaking and
following a 12,000 × g centrifugation at 4◦C for 15min, the
aqueous phase was harvested. 0.5mL 75% ethanol was added
and the RNA precipitated for 10min at room temperature
before loading on a NucleoSpin RNA column. RNA extraction
was then carried on following the manufacturer’s instructions,
including a DNase step. RNA was eluted from the column
with 40 µL RNase-free water and the quality and quantity
of the extracted RNA was determined using an Agilent 2100
Bioanalyzer (Agilent Technologies, Santa Clara, CA, USA) and
a Qubit 2.0 Fluorometer (Thermofisher). All the RNA samples
used for this study were of high quality (RNA integrity number
RIN > 8) and libraries were prepared with TruSeq RNA Library
Prep Kit v2 (Illumina). Total mRNA libraries were randomly
multiplexed with 8 samples per lane and sequenced on the
Illumina HiSeq2500 platform. The Illumina BCL output files
with base calls and qualities were converted into FASTQ file
format and demultiplexed with the CASAVA (v1.8.2) software.
The RNAseq data are available in the European Nucleotide
Archive (http://www.ebi.ac.uk/ena) under the accession numbers
PRJEB37564 and PRJEB37565 for the in vitro and in vivo
activated DC, respectively.
For the blood mononuclear cell subsets incubated with or
without TLR ligands, between 19.2 and 33.3 million single-
end reads were available per sample. For the tonsil and lymph
node subsets, between 28.1 and 37.0 million single-end reads
were available per sample. The quality of the data was assessed
using fastqc v.0.11.5 and RSeQC v. 2.6.4 (18). The reads were
mapped to the pig reference genome (assembly Sscrofa11.1)
using HiSat2 v. 2.1.0 (19). FeatureCounts v. 1.6.0 (20) was used
to count the number of reads overlapping with each gene as
specified in the Ensembl annotation build 91. Differential gene
expression analysis was performed with DESeq2 v. 1.18.1 (21) in
R v. 3.4.2. For each of the TLR-stimulated blood mononuclear
cell subsets, we compared stimulated cells to their corresponding
unstimulated control. For the PAM3Cys-stimulated samples,
we also performed pairwise comparisons of cell subsets. For
pDC, the samples from the different TLR stimulations were also
compared between each other.
To compare gene expression profiles of DC subtypes across
tissues, the data from lymph node and tonsil populations
were combined with previously generated RNA-Seq data from
blood (3). For consistency, older datasets were reanalyzed as
described above. The cell-type specific transcription signatures
of the different subsets were compared as described previously
(22). For each tissue, subtype-specific gene expression signatures
were obtained by performing pairwise tests of differential gene
expression between each cell type and a pool of all remaining cell
types. All gene lists were then sorted based on FDR-adjusted p-
values to have the most highly upregulated genes at the top and
the most strongly downregulated genes at the bottom.
Each cell type-specific signature from a given tissue was
compared with all signatures from a second tissue using the
R package OrderedList v. 1.44.0 (23). This tool determines the
number of shared elements in the tails of two lists and calculates a
final similarity score where genes receive more weight the closer
they are to the top or bottom of the list. This ensures that the
score is dominated by the genes showing the most significant
differential expression. We report similarity scores based on n
= 1,000 genes each from the top and bottom of the lists. The
relative similarity among the cell types was generally consistent
for other values of n (assessed for values between 100 and 2500).
To assess the statistical significance of the similarity scores, the
observed values were compared with a null distribution obtained
by reshuffling the genes. Because invariant genes do not influence
the similarity score, the middle 60% of genes were excluded from
the permutations.
The molecular signatures of in vivo activated DC were also
analyzed by “ranked gene set enrichment analysis” (GSEA) (24)
using a selection of blood transcription modules (BTM) defined
by Li et al. (25) and modified for pigs as previously described
(26). For this selection, all cell-type specific and non-classified
BTM [“TBA” in Li et al. (25)] were omitted resulting in 86 BTM
(M4.0, M4.1, M4.2, M4.3, M4.4, M4.5, M4.6, M4.7, M4.8, M4.10,
M4.12, M5.0, M6, M13, M14, M15, M16, M22.0, M22.1, M23,
M24, M25, M27.0, M27.1, M28, M29, M33, M34, M37.3, M38,
M39, M40, M43.0, M43.1, M50, M51, M53, M59, M64, M65,
M67, M68, M71, M75, M76, M77, M78, M86.0, M86.1, M92,
M95.0, M95.1, M103, M109, M111.0, M111.1, M112.0, M112.1,
M114.1, M115, M119, M122, M127, M129, M138, M139, M143,
M144,M146,M147,M150,M158.0, M158.1, M165,M168,M169,
M200, M209, M216, M219, M225, M226, M230, M250, S10, S11),
which mainly inform on antigen presentation, inflammation,
interferon (IFN) type I responses, metabolic processes and cell
cycle. To compare the module activity between highly and low
virulent CSFV infection, normalized enrichment scores (NES) of
significantly enriched modules (false discovery rate, q-value <
0.05) were displayed.
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RESULTS
Transcription Profiles of Blood cDC1,
cDC2, pDC and Monocytes Following
PAM3Cys Stimulation
As a first step, we applied RNA-Seq to characterize, in a
comparative manner, the activation profiles of sorted blood
DC including cDC1, cDC2, and pDC as well as monocytes,
all defined as previously described (3). Due to limitations in
cell numbers of the rare cDC1 subset following sorting, we
focused on the stimulation of the different populations with
the TLR1/TLR2 agonist PAM3Cys which was selected based
on its ability to directly activate all four targeted subsets (3).
When assessing the number of significantly (padj<0.05) up-
and downregulated genes, cDC1 and cDC2 subsets appeared
to be the most responsive to PAM3Cys stimulation, with
over 4000 differentially regulated genes (Figure 1A). Over
1000 genes were differentially regulated in pDC following
PAM3Cys stimulation, comprising mostly upregulated genes
(827 upregulated and 265 downregulated). In monocytes, despite
a higher expression of TLR1 and TLR2 at homeostasis (3), a lower
amount of differentially regulated genes (93 upregulated and 176
downregulated) was observed (Figure 1A).
A switch in chemokine receptor expression is a hallmark
of DC activation (2). Following PAM3Cys stimulation of DC
but not monocytes, we observed a significant decrease of CCR2
mRNA, combined with a significant increase of CCR7 mRNA,
the latter coding for the key chemokine receptor responsible for
migration to the lymph nodes (Figure 1B). All three DC subsets
displayed also an increase in CXCR5 expression (Figure 1B), a
receptor involved in the migration toward B-cell follicles in the
lymph nodes (2). Only cDC2 displayed a significant decrease
in CCR5 and CCR6 expression. Interestingly, stimulation of
DC but not monocytes also induced upregulation of a number
of cytokine receptor genes, including IL2RA, IL7R, IL17RC,
and IL21R (Figure 1B), some of which encode receptors for
T-cell cytokines.
Co-stimulatory molecules CD40, CD80, and CD83 were
upregulated in all three DC subsets but not in monocytes after
stimulation, while only cDC1 and pDC significantly increased
their CD86 expression (Figure 1C). The inhibitory molecules
CD200 (OX-2) and CD274 (PD-L1) were also upregulated in all
three DC subsets.
The PAM3Cys stimulation also induced the expression of
several cytokine and chemokine genes. The three DC subsets
significantly upregulated TNF, IL7 and CCL22 (Figure 1D), the
latter encoding a chemokine attracting Th2 and regulatory T
cells (27). The two cDC displayed a significant increase in IL1A,
IL1B, and in a broad range of chemokine genes (CCL3L1, CCL5,
CCL20, CXCL2, and CXCL8). Conventional DC type 1 and pDC
were the only subsets showing an increase in CXCL10, while only
cDC1 significantly upregulated IL12B (Figure 1D). With respect
to cytokines, monocytes were not very responsive to PAM3Cys
stimulation, with a significant upregulation of only CCL3L1.
Stimulation with PAM3Cys also had an impact
on PRR expression by porcine DC and monocytes
(Supplementary Figure 1). The receptors for PAM3Cys
TLR1 and TLR2 were upregulated by cDC1 and cDC2, and
by pDC and cDC2, respectively. Both cDC subsets also
significantly upregulated their expression of TLR10, while their
expression of TLR3, TLR4, TLR8, and TMEM173 (STING)
was downregulated. Stimulation with PAM3Cys also induced
a significant upregulation of the RIG-I like receptors (RLR)
DDX58 (RIG-I) and IFIH1 (MDA5), as well as of the NOD-like
receptor (NLR) NLRP3 by pDC. Although no changes were
observed for TLR expression in monocytes, their expression
of DHX58 (LGP2), DDX58 and IFIH1 was downregulated
(Supplementary Figure 1A). In most cases, the TLR stimulation
promoted the expression of many signaling molecules of the
NFκB and JAK-STAT pathways as well as of PRR adaptor
molecules (Supplementary Figures 1B,C). Interestingly, these
responses were seen in DC but not in monocytes.
Transcriptional Profile of pDC After
Stimulation With Different TLR Ligands
In a previous study, we showed that blood pDC were activated by
a wide range of TLR ligands and were key cells in the activation
of cDC after TLR7 and TLR9 stimulation (3). Therefore, we
were particularly interested in comparing immune response
profiles of porcine pDC to different TLR ligands. In parallel to
the PAM3Cys stimulation shown in Figure 1, sorted pDC from
the same animals were also stimulated with the TLR ligands
poly I:C (TLR3), gardiquimod (TLR7), resiquimod (TLR7/8), or
CpG ODN (TLR9), recognized by receptors highly expressed
in porcine pDC. These four ligands were all more efficient
than PAM3Cys in inducing either up- or downregulation of
genes following stimulation, when compared to the unstimulated
control (Figure 2A). Resiquimod induced the strongest changes
in gene expression, followed by CpG ODN and poly I:C.
In terms of activation markers, all TLR ligands induced a
significant downregulation of CCR2 mRNA and a significant
upregulation of CCR7 mRNA (Figure 2B). Transcription of
CXCR5 was also induced by all TLR ligands with the exception
of gardiquimod. Stimulation with TLR ligands also had a potent
impact on cytokine receptor expression, inducing transcription
of IL2RA, IL7R, IL10RA, IL12RB2, and IL21R. In many cases the
strongest effects were found with poly I:C, resiquimod and CpG
ODN (Figure 2B).
Stimulation with PAM3Cys, poly I:C, resiquimod and CpG
ODN also induced the upregulation of several costimulatory
molecules such as CD40, CD80, CD83, CD86, and TNFRSF11A
(RANK), with the noticeable exception of CD80 following
CpG ODN stimulation and TNFRSF11A following poly I:C
stimulation (Figure 2C). These four TLR ligands also induced
a significant transcriptional upregulation of CD200 and CD274,
both coding for T-cell inhibitory molecules.
A broad range of cytokine and chemokine genes was
upregulated in pDC following TLR-ligand stimulation
(Figures 3A,B). CpG ODN was found to be the main inducer
of many type I interferon genes (10 IFNα genes, 3 IFNω
genes, and IFNβ1) (Figure 3A). Poly I:C and resiquimod also
increased the expression of IFN-ALPHA-1, IFN-ALPHA-13,
IFN-OMEGA-1, and IFNB1 genes, but to a lesser extent than
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FIGURE 1 | Transcription profiles of porcine blood mononuclear phagocytes following PAM3Cys stimulation. cDC1, cDC2, pDC and monocytes from three different
animals were sorted by FACS and stimulated for 3 h with 10µg/ml of PAM3Cys or left unstimulated as control. (A) Number of significantly regulated genes (padj <
0.05) when comparing PAM3Cys-stimulated cells to the corresponding non-stimulated control. (B) Expression of selected chemokine and cytokine receptor genes as
log2 fold change between PAM3Cys-stimulated cells and their corresponding non-stimulated control. (C) Expression of selected costimulatory molecule genes as log2
fold change between PAM3Cys-stimulated cells and their corresponding non-stimulated control. (D) Expression of selected chemokine and cytokine genes as log2
fold change between PAM3Cys-stimulated cells and their corresponding non-stimulated control. DESeq2 analysis * padj<0.05, ** padj < 0.01, *** padj < 0.0001.
CpG ODN. Stimulations with Poly I:C, resiquimod and CpG
ODN all induced a significant upregulation of CXCL10, a
chemokine involved in the recruitment of activated T- and
B lymphocytes and a well-known IFN-responsive gene (28).
Several other chemokines were also upregulated following
stimulation, with unique expression profiles for different TLR
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FIGURE 2 | Transcription profiles of porcine blood pDC stimulated with TLR ligands. pDC from three different animals were sorted by FACS and stimulated with
10µg/ml of PAM3Cys, 10µg/ml poly I:C, 5µg/ml gardiquimod, 5µg/ml resiquimod, 5µg/ml CpG ODN D32, or were left unstimulated as control. (A) Number of
significantly regulated genes (Padj <0.05) when comparing TLR ligand-stimulated pDC to control pDC. (B) Expression of selected chemokines and cytokines receptor
genes as log2 fold change between TLR ligand-stimulated pDC and control pDC. (C) Expression of selected costimulatory molecule genes as log2 fold change
between TLR ligand-stimulated pDC and control pDC. DESeq2 analysis * padj < 0.05, ** padj < 0.001, *** padj < 0.0001. For each gene, different letters indicate
statistical significance between two TLR-ligand stimulation groups as calculated by DESeq2 analysis.
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FIGURE 3 | Transcription profiles of porcine blood pDC stimulated with TLR ligands. pDC from 3 different animals were sorted by FACS and stimulated with 10µg/ml
of PAM3Cys, 10µg/ml poly I:C, 5µg/ml gardiquimod, 5µg/ml resiquimod, 5µg/ml CpG ODN D32, or were left unstimulated as control. (A) Expression of selected
type I interferon genes as log2 fold change between TLR ligand-stimulated pDC and control pDC. (B) Expression of selected cytokine and chemokine genes as log2
fold change between TLR ligand-stimulated pDC and control pDC. DESeq2 analysis * padj < 0.05, ** padj < 0.001, *** padj < 0.0001. For each gene, different letters
represent statistical significance between two TLR-ligand stimulation groups as calculated by DESeq2 analysis.
ligands (Figure 3B). CpG ODN and resiquimod were the
only ligands inducing a significant upregulation of the genes
coding for IL-12p35 and IL-12p40 (IL12A and IL12B), thus
suggesting the production of the Th1-promoting cytokine
IL-12p70 by pDC. Transcription of the pro-Th1 cytokine
gene IL18 was increased following treatment by all ligands.
The expression of IL7, known to be essential for lymphocyte
development and homeostasis (29), and IL27, implied in
regulating T-cell responses (30), was induced by all TLR ligands
tested, with resiquimod and CpG ODN inducing higher levels
(Figure 3B).
The expression of PRR was differentially regulated, depending
both on the type of PRR and on the type of stimulus. A
significant downregulation of TLR1, TLR6, TLR9, and TLR10
was seen irrespective of the TLR ligand used for stimulation
(Supplementary Figure 2A). For TLR3 and TLR7 expression,
a significant upregulation was observed following stimulation
with poly I:C and CpG ODN, while resiquimod induced a
downregulation of these genes. A similar pattern was observed
for TLR8 expression, but only the downregulation induced
by resiquimod stimulation was found to be significant. The
RLRs DHX58, DDX58, and IFIH1 were all upregulated after
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FIGURE 4 | Identification and phenotyping of tonsil and mandibular lymph node mononuclear phagocytes isolated from tonsils and lymph nodes. The top panel
shows the gating strategy following multicolor FCM staining using antibodies against CD14, CD172a, CADM1, and CD4. After excluding doublets, cells high in
(Continued)
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FIGURE 4 | FSC/SSC were gated, followed by gating on the CD14high population. Among the CD14− cells, cDC1 were gated as CD14− CD172a−/low CADM1+,
cDC2 as CD14−CD172a+CADM1+, and pDC as CD14−CD172a+CADM1+CD4+. The cell-surface expression of CD123, CD205, CD115, wCD11R1, CD1, MHC II,
CD80/86, CD207 and CD163 was assessed for cDC1, cDC2, pDC and monocytic cells. Histograms show staining for each of the sub-populations with the
corresponding FMO control (gray histograms). Across tissues, the profiles displayed for a given marker were obtained from the same animal and are representative of
three independent experiments using three different animals. “na” no data available due to low number of cells.
PAM3Cys and CpG ODN treatment, and poly I:C induced
an even more significant upregulation of DHX58 and DDX58
expression. Transcription of NLRP3 was enhanced by all TLR
ligands, with poly I:C, resiquimod and CpG ODN inducing
again the strongest effect (Supplementary Figure 2A). We also
found a profound stimulatory effect of all TLR ligands on
certain signaling molecules of the NFκB pathway and the JAK-
STAT pathway as well as on some PRR adaptor molecules
(Supplementary Figures 2B,C).
Identification of cDC1, cDC2, and pDC in
Lymphoid Tissue by Flow Cytometry
Having characterized the immune response profiles of DC
subsets after in vitro stimulation, we wanted to validate this
data using an in vivo CSFV infection model. In particular, we
were interested whether the observations made in vitro with
TLR-stimulated blood DC were comparable to those found in
lymphoid tissue DC subsets from infected animals.
Prior to infection experiments, in-depth phenotypic analyses
were performed in order to ensure proper identification of
porcine DC subsets in lymphoid tissues by flow cytometry. To
this end, we harvested tonsils and mandibular lymph nodes
from SPF pigs and performed the same staining protocol
employed to define DC subsets in porcine blood (3). After gating
on cells with a higher FSC and SSC, we defined monocytic
cells as CD14high, and gated on two CD172a/CADM1-defined
subsets within the CD14 negative fraction, with the putative
cDC1 being CD14−CD172a−CADM1+, and the putative cDC2
being CD14−CD172a+CADM1+. For pDC, we gated on
CD14−CD172+CADM1− cells, followed by a gate on CD4+
cells (Figure 4, top panels). Using this gating, we investigated
the expression of a range of surface markers on each of these
subsets. Most of these markers had been used previously to
characterize porcine DC subsets from blood and we observed
similar expression patterns for DC subsets from tonsils and
mandibular lymph nodes. As in the peripheral blood, putative
pDC in lymph nodes and tonsils were the only subset to
express CD123 (IL3RA). Putative cDC1 expressed high levels
of CD205 and wCD11R1 while putative cDC2 expressed CD1,
CSF1R (CD115) and CD207. All DC populations expressed
class II MHC and costimulatory molecules CD80/86, with
both putative cDC subsets expressing very high levels of
MHC II, and higher levels of CD80/86 when compared to
pDC. The CD14high monocytic cell subset was phenotypically
similar to cDC2, but expressed lower levels of CD1 and
higher levels of CD115. In the mandibular LN, but not the
tonsils, monocytic cells also expressed high levels of CD163
(Figure 4).
Transcriptional Characterization of DC
Subsets Isolated From Secondary
Lymphoid Organs
To verify the proposed identity of the phenotypically defined
subsets, we FACS-sorted these cells using the gates described in
Figure 4 and performed RNA-Seq. For the LN, we pooled cells
from mandibular and retropharyngeal LN to obtain sufficient
amounts of RNA. The transcriptomic data confirmed that only
the cDC1, cDC2, and pDC subsets but not the CD14high subset
expressed the bona fide DC-specific marker FLT3, and the
expression of CD14, CADM1, and CD4 matched with what
was observed by flow cytometry (Supplementary Figures 3A,B
for LN and tonsils, respectively). Making use of the data we
published previously with blood DC subsets and monocytes (3),
we performed a principal component analysis on all samples
using the 500 most variable genes (Figure 5A). Regardless of the
compartment the cells were isolated from (blood, tonsils or LN),
cDC1, cDC2 and pDC were clustering with their counterparts
from the other tissues, and CD14high cells clustered with
monocytes and monocyte-derived macrophages (MDM). This
was confirmed by computing the organ-dependent similarity
scores for the transcriptional profiles of each cell-type, which
included the following comparisons: blood vs. LN, blood vs.
tonsils and LN vs. tonsils (Figure 5B). For both, tonsils and LN
cells, the transcriptional signature of each DC subset was similar
to the corresponding blood DC subset. The only exception
was that cDC1 from tonsils also shared some similarity with
blood cDC2. In addition, the CD14high population showed
high transcriptional similarity to monocytes, but no significant
similarity to any of the DC subsets.
Finally, to confirm the correct identification of DC subsets,
we investigated a number of genes known to be differentially
expressed in a subset-dependent manner. Table 1 shows selected
genes that were expressed specifically either by all three DC
subsets (cDC1, cDC2, and pDC) or by both cDC subsets in
tonsils and LN. All three DC subsets specifically expressed
the pan-DC markers FLT3 and BCL11A, and the gene coding
for vinculin (VCL), an important component of podosomes
involved in antigen sampling (31). The expression pattern of
IRF4 and IRF8 matched what was described in mouse or
human, with pDC co-expressing both genes and cDC1 and
cDC2 expressing mainly IRF8 and IRF4, respectively. Four genes
found to be specifically expressed by both cDC subsets in
porcine blood, namely NAV1, PAK1, SIGIRR, and NAPSA, were
also overexpressed by cDC1 and cDC2 subsets from secondary
lymphoid organs. The highly dominant expression of cross-
species cDC1-specific genes including BATF3, XCR1, ANPEP
(coding for CD13), DPP4 (CD26), GCSAM, CLNK, SNX22, or
RAB7B (Table 2) confirmed the correct identification of this
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FIGURE 5 | Comparison of transcription profiles of mononuclear phagocytes isolated from tonsils and LN (cDC1, cDC2, pDC, CD14high) with their blood counterparts
(cDC1, cDC2, pDC, monocytes) as well as with monocyte-derived macrophages (MDM) at homeostasis. Cells isolated from porcine tonsils or lymph nodes were
sorted by FACS and their RNA was sequenced. (A) Plot of the first 2 axes from a principal component analysis (PCA) based on the 500 most variable genes. For each
compartment (blood, tonsils, lymph nodes), data were obtained from three different animals. (B) Each cell-type specific signature was compared to all signatures of
subsets from a second tissue and a similarity score was calculated. To assess the statistical significance of the similarity scores, the observed values were compared
to a null distribution obtained by reshuffling the genes. *** = empirical p-value < 0.001.
subset in porcine lymphoid tissue. In addition, genes highly over-
expressed in cDC1 in porcine blood such as SCIMP, CD34, or
CD226 were also found in lymphoid tissue cDC1. Interestingly,
we also found high levels of ITGAE (CD103) transcripts in this
subset, contrasting with porcine peripheral blood cDC1 (3). The
integrin subunit CD103 is well-described in other species as a
marker for cDC1 at mucosal surfaces and in secondary lymphoid
organs (32).
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TABLE 1 | cDC-specific and DC-specific differentially regulated genes.
Gene cDC1 cDC2 pDC CD14high
FLT3 LN 9,506 ± 4,257a 8,096 ± 674 7,997 ± 404 128 ± 35
Tonsils 16,282 ± 4,106 7,216 ± 2,406 7,224 ± 944 152 ± 104
BCL11A LN 1,631 ± 153 1,587 ± 258 8,943 ± 108 360 ± 102
Tonsils 2,295 ± 189 2,580 ± 351 8,313 ± 560 570 ± 386
VCL LN 810 ± 23 3,137 ± 59 4,028 ± 205 278 ± 78
Tonsils 1,460 ± 142 2,940 ± 952 3,115 ± 675 535 ± 43
IRF4 LN 1,432 ± 730 1,631 ± 192 6,126 ± 687 536 ± 180
Tonsils 1,407 ± 624 2,078 ± 448 6,195 ± 1,332 876 ± 563
IRF8 LN 58,913 ± 23,400 3,323 ± 595 1,09,432 ± 2,441 7,592 ± 1,161
Tonsils 69,736 ± 11,350 8,346 ± 926 1,08,212 ± 13,113 11,944 ± 1,550
SIGIRR LN 283 ± 172 543 ± 148 7 ± 4 84 ± 14
Tonsils 244 ± 100 585 ± 27 96 ± 77 163 ± 120
PAK1 LN 8,001 ± 2,785 33,717 ± 1,396 20 ± 3 4,484 ± 1,040
Tonsils 14,883 ± 3,505 30,987 ± 7,543 120 ± 155 6,162 ± 1,166
NAV1 LN 1,533 ± 571 2,005 ± 60 388 ± 60 1,107 ± 395
Tonsils 1,983 ± 340 1,903 ± 675 298 ± 127 683 ± 44
NAPSA LN 1,324 ± 398 2,164 ± 611 70 ± 50 79 ± 51
Tonsils 2,069 ± 117 2,926 ± 249 348 ± 320 418 ± 311
aMean number of reads ± SD.
TABLE 2 | Differentially regulated genes in cDC1.
Gene cDC1 cDC2 pDC CD14high
XCR1 LN 12,854 ± 5,720a 22 ± 18 147 ± 149 106 ± 23
Tonsils 16,581 ± 1,297 52 ± 51 769 ± 634 743 ± 494
BATF3 LN 2,016 ± 728 787 ± 99 2 ± 2 462 ± 166
Tonsils 2,920 ± 990 512 ± 155 12 ± 8 1,510 ± 589
ANPEP LN 28,706 ± 12,442 484 ± 134 10 ± 3 47 ± 43
(CD13) Tonsils 2,920 ± 990 512 ± 155 12 ± 8 1,510 ± 589
DPP4 LN 2212 ± 1003 933 ± 160 1,225 ± 667 88 ± 10
(CD26) Tonsils 34755 ± 8044 1164 ± 444 9 ± 13 233 ± 144
SCIMP LN 5,261 ± 455 133 ± 20 102 ± 75 469 ± 309
Tonsils 8,820 ± 566 2,528 ± 894 1,005 ± 591 1,233 ± 1,018
ITGAE LN 2,927 ± 1,135 103 ± 55 144 ± 42 92 ± 27
(CD103) Tonsils 4,482 ± 790 1,046 ± 366 245 ± 18 210 ± 118
CD226 LN 1,408 ± 504 45 ± 28 3 ± 3 6 ± 6
Tonsils 903 ± 225 15 ± 15 6 ± 9 4 ± 5
CD34 LN 1,809 ± 714 310 ± 9 284 ± 59 194 ± 153
Tonsils 2,890 ± 493 414 ± 181 206 ± 99 50 ± 18
GCSAM LN 1,154 ± 246 51 ± 18 19 ± 16 25 ± 20
Tonsils 1,962 ± 369 226 ± 198 278 ± 183 335 ± 175
RAB7B LN 1,093 ± 356 5 ± 5 6 ± 4 60 ± 21
Tonsils 1,080 ± 155 5 ± 3 3 ± 3 191 ± 75
CLNK LN 3,052 ± 1,837 7 ± 0 0 4 ± 6
Tonsils 2,695 ± 556 3 ± 5 0 5 ± 5
SNX22 LN 1,007 ± 312 39 ± 18 22 ± 9 13 ± 2
Tonsils 1520 ± 351 53 ± 9 31 ± 11 22 ± 19
a Mean number of reads ± SD.
TABLE 3 | Differentially regulated genes in cDC2.
Gene cDC1 cDC2 pDC CD14high
FCER1A LN 5 ± 0a 241 ± 114 54 ± 59 15 ± 18
Tonsils 20 ± 16 295 ± 112 67 ± 67 13 ± 16
MS4A2 LN 638 ± 152 32,459 ± 3,533 979 ± 995 5,660 ± 4,419
(FCER1B) Tonsils 1,602 ± 860 24,433 ± 8,617 304 ± 200 1,590 ± 130
NOTCH4 LN 1,590 ± 344 5,688 ± 1,676 239 ± 45 777 ± 333
Tonsils 2,104 ± 582 6,706 ± 1,972 258 ± 42 838 ± 479
CD207 LN 6 ± 3 3,450 ± 569 1 ± 0 89 ± 21
Tonsils 17 ± 23 1,519 ± 827 0 ± 0 42 ± 23
FSCN1 LN 1,130 ± 45 6,936 ± 3,973 48 ± 49 3,290 ± 1,425
Tonsils 846 ± 279 3,799 ± 985 99 ± 51 1,424 ± 228
CD1E LN 120 ± 45 6,178 ± 2,671 4 ± 1 2,539 ± 912
Tonsils 130 ± 112 10,845 ± 3,570 53 ± 63 812 ± 562
SLCO3A1 LN 1,043 ± 264 3,467 ± 280 972 ± 88 584 ± 262
Tonsils 815 ± 207 4,003 ± 634 946 ± 223 361 ± 167
PLA2G2D LN 339 ± 4 3,374 ± 1,956 12 ± 15 789 ± 894
Tonsils 1,211 ± 625 10,317 ± 4,997 57 ± 54 1,579 ± 1,088
aMean number of reads ± SD.
Table 3 displays selected genes that were overexpressed
specifically by the cDC2 subset and confirm their identity. As for
their counterparts in porcine blood, FCER1A and NOTCH4 were
specifically expressed by the cDC2 subset in both lymph nodes
and tonsils. Interestingly, transcription ofMS4A2, coding for the
β subunit of the high-affinity IgE receptor, as well as transcription
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TABLE 4 | Differentially regulated genes in pDC.
Gene cDC1 cDC2 pDC CD14high
TCF4 LN 1,523 ± 524a 886 ± 66 22,483 ± 1,668 1,439 ± 130
(E2-2) Tonsils 1,843 ± 368 1,677 ± 412 19,428 ± 4,631 1,947 ± 291
RUNX2 LN 16 ± 1 379 ± 50 869 ± 37 87 ± 31
Tonsils 41 ± 3 152 ± 105 590 ± 174 116 ± 23
CD8B LN 2 ± 1 1 ± 1 3942 ± 657 10 ± 9
Tonsils 15 ± 21 9 ± 13 8,370 ± 1,635 4 ± 5
CD36 LN 936 ± 450 163 ± 39 23,382 ± 505 113 ± 17
Tonsils 1,857 ± 327 175 ± 48 21,284 ± 1,889 35 ± 22
CLEC12A LN 248 ± 92 46 ± 12 2,886 ± 347 20 ± 9
Tonsils 334 ± 42 133 ± 67 2,854 ± 1,087 82 ± 96
UNC93B1 LN 3,632 ± 1,096 6,277 ± 222 15,497 ± 1,169 5,734 ± 535
Tonsils 4,668 ± 1,279 6,560 ± 1,604 16,275 ± 2,951 6,025 ± 2,452
NOTCH3 LN 2 ± 1 5 ± 3 2,137 ± 182 247 ± 231
Tonsils 0 11 ± 9 2,106 ± 675 1 ± 1
TRAF4 LN 1,591 ± 577 652 ± 407 6,334 ± 382 157 ± 90
Tonsils 1,387 ± 332 1,004 ± 315 6,485 ± 856 502 ± 381
PLAC8 LN 686 ± 211 999 ± 65 10,817 ± 187 1,885 ± 1,454
Tonsils 819 ± 315 1,132 ± 327 11,223 ± 1,654 819 ± 274
BLNK LN 1,551 ± 1,024 714 ± 48 23,751 ± 2,093 2,657 ± 259
Tonsils 1,474 ± 427 1,616 ± 567 27,304 ± 3,353 1,810 ± 349
LRP8 LN 612 ± 275 929 ± 123 12,756 ± 1,723 793 ± 74
Tonsils 733 ± 43 1,603 ± 249 11,400 ± 2,881 1,166 ± 627
C2 LN 45 ± 11 2,246 ± 563 16,072 ± 1,410 5,387 ± 371
Tonsils 86 ± 93 2,780 ± 917 16,483 ± 3,485 3,486 ± 966
C3 LN 52 ± 19 360 ± 30 31,604 ± 4,260 376 ± 77
Tonsils 60 ± 55 357 ± 66 35,257 ± 15,129 1,101 ± 765
CD93 LN 95 ± 30 4 ± 3 6,522 ± 3,428 33 ± 15
Tonsils 117 ± 83 12 ± 8 6,105 ± 3,210 48 ± 36
CMKLR1 LN 19 ± 2 203 ± 107 4,218 ± 698 933 ± 337
Tonsils 23 ± 16 228 ± 59 4,601 ± 855 466 ± 137
aMean number of reads ± SD.
of CD207 (Langerin) were found to be restricted to the cDC2
subset. The cDC2-associated genesCD1E (33) and SLCO3A1 (34)
and genes associated with migratory DC or lymphoid-organ DC
such as FSCN1 (35) and PLA2G2D (36) were also expressed in
porcine cDC2 from secondary lymphoid tissues.
Selected genes expressed specifically in pDC are shown in
Table 4, again confirming their correct identification in lymphoid
tissue. The expression of the two pDC-specific transcription
factors TCF4 (E2-2) and RUNX2 was restricted to the pDC
subset. As with their blood counterparts, we found a subset-
specific expression of CD36, PLAC8, BLNK, LRP8, NOTCH3,
TRAF4, CLEC12A, C2, C3, and CD93 in pDC from lymphoid
tissues. CMKLR1, encoding the receptor for chemerin, which is
specifically expressed by pDC in human blood (37), was also
expressed in pDC from LN and tonsils.
Finally, Table 5 displays genes that were expressed specifically
in the CD14high subset, including CD68, SLC11A1, MAFB,
TFEC, FCGR1A (CD64), SIGLEC1 (CD169), ZFP36L1, and
CHIT1. Transcription of these genes confirmed the monocytic
lineage identity of the CD14high subset. The latter two genes
are associated with monocyte/macrophage development
and monocyte-to-macrophage differentiation, respectively.
Altogether, these data demonstrate that the gating strategy
presented in Figure 4 defines distinct populations within lymph
nodes and tonsils that can be attributed to cDC1, cDC2, pDC
and monocytic cells.
Moreover, the cell subsets isolated from tonsils and lymph
nodes displayed similar PRR expression to their previously
described counterparts in porcine blood, with cDC2 and the
CD14high subset expressing TLR2, TLR4, and NOD1, and both
cDC subsets and the CD14high subset expressing NLRP3, CASP1,
and TLR8 (Supplementary Figures 3C,D). The expression of
TLR3 was restricted to the pDC subset, as in peripheral blood.
This subset also displayed the highest expression of TLR9 and
TMEM173 (coding for the cytoplasmic DNA sensor STING). The
RLR genes DDX58, IFIH1 and DHX58 were expressed by all four
mononuclear-phagocyte populations with the CD14high subset
expressing the highest levels. The macrophage-specific C-type
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TABLE 5 | Differentially regulated genes in CD14high cells.
Gene cDC1 cDC2 pDC CD14high
NFIL3 LN 384 ± 84a 812 ± 43 102 ± 19 9,396 ± 857
Tonsils 1,008 ± 382 1,887 ± 824 312 ± 67 29,942 ± 11,189
MAFB LN 76 ± 4 3,267 ± 1,406 63 ± 27 28,837 ± 7,820
Tonsils 251 ± 174 2981 ± 182 123 ± 38 57,937 ± 18,638
FCGR1A LN 139 ± 11 139 ± 27 153 ± 45 578 ± 159
(CD64) Tonsils 92 ± 53 121 ± 36 130 ± 106 298 ± 52
CD68 LN 760 ± 304 854 ± 96 104 ± 23 9,698 ± 3,643
Tonsils 789 ± 174 1,404 ± 138 146 ± 43 9,759 ± 3,182
CD163 LN 4 ± 3 188 ± 122 4 ± 1 19,923 ± 4,775
Tonsils 211 ± 299 3,076 ± 1,122 99 ± 140 37,033 ± 6,409
SIGLEC1 LN 0 11 ± 2 1 ± 1 2,194 ± 792
(CD169) Tonsils 0 19 ± 16 18 ± 10 545 ± 362
CCR1 LN 51 ± 39 1,746 ± 568 15 ± 9 7,810 ± 593
Tonsils 87 ± 99 1,929 ± 596 35 ± 44 27,185 ± 6,502
MMP9 LN 40 ± 35 51 ± 63 1 ± 1 272 ± 158
Tonsils 134 ± 150 432 ± 329 54 ± 60 6,452 ± 2,785
TFEC LN 56 ± 12 368 ± 114 378 ± 224 2,963 ± 936
Tonsils 56 ± 35 1,025 ± 191 271 ± 203 5,038 ± 1,639
SLC11A1 LN 8 ± 4 165 ± 53 11 ± 14 3,930 ± 1,805
Tonsils 39 ± 55 132 ± 53 7 ± 9 12,827 ± 3,665
ZFP36L1 LN 1,661 ± 169 2,194 ± 353 836 ± 118 4,956 ± 1,225
Tonsils 2,014 ± 185 2,321 ± 516 1190 ± 125 4,398 ± 1,543
CHIT1 LN 0 0 0 1,460 ± 290
Tonsils 0 0 0 2,414 ± 656
a Mean number of reads ± SD.
lectin receptor CLEC4E (MINCLE) was dominantly expressed by
the CD14high subset.
Transcriptional Response of DC in LN
Following Virus Infection
Following the identification and characterization of porcine DC
subsets in lymphoid tissue at homeostasis, our aim was to
determine their specific early transcriptional response to an acute
viral infection in vivo. To this end, we used CSFV infection as a
model for an acute systemic virus infection associated with strong
innate immune activation, which has been proposed to be amajor
factor contributing to immunopathology of the disease (9). The
planning of the study was based on the hypothesis that CSFV
would enter the host through the tonsils after oronasal infection,
likely representing a natural route of infection (38). We reasoned
that the virus should have reached the draining lymph nodes 1
day later. Being interested in early time points, we selected 18 and
42 h post infection (p.i.) for collection of tonsils and lymph nodes,
respectively. Both of these time points are before the onset of
viremia, which is 3 days post infection with highly virulent strains
such as Eystrup (39) or Brescia (40). With the PdR strain, viremia
is delayed and is detected only at low levels (8). The time points
were also selected based on the pathogenesis of virulent CSFV,
which was shown to induce lymphoid depletion at 1–2 days post
infection (40, 41).
Pigs were infected with a highly virulent strain of CSFV
responsible for acute disease [vEy-37 derived from the Eystrup
strain (7)] or a low-virulent strain leading to chronic infection
(Pinar del Rio, PdR) to understand how DC might contribute
to the different disease outcomes. The cDC1, cDC2, pDC, and
CD14high subsets were sorted from the tonsils of infected animals
at 18 h p.i. or from the draining mandibular and retropharyngeal
lymph nodes at 42 h p.i. At these very early time points, no
clinical signs and no viremia were detected in the animals. High-
throughput sequencing was then performed on RNA isolated
from sorted cells and the transcriptional profile of each subset
was compared between infected and control animals. Very few
genes were significantly regulated in the subsets isolated from the
tonsils at 18 h post infection. With the PdR strain for example,
the expression of 14 genes for pDC, 11 genes for cDC1, and 1
gene for cDC2 changed significantly (padj<0.05). In contrast, at
42 h p.i. with the highly virulent Eystrup strain, a high number of
genes were differentially expressed in cDC subsets and CD14high
cells isolated from the LN (1976 genes for cDC1, 2685 genes for
cDC2 and 1980 genes for CD14high cells), while pDC displayed
fewer regulated genes (537) (Figure 6A). At 42 h p.i. with the low-
virulent PdR strain, more genes were differentially regulated in
pDC (1451 genes), but fewer in the other subsets (623 for cDC1,
1141 for cDC2 and 617 for CD14high).
Figure 6B demonstrates the characteristic
chemokine receptor switch in activated DC for both cDC subsets
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FIGURE 6 | Transcription profiles of LN mononuclear phagocytes after infection with a highly virulent (Eystrup) or a low virulent (PdR) strain of CSFV. cDC1, cDC2,
pDC, and CD14high populations were isolated from mandibular and retropharyngeal LN of animals either infected with Eystrup, PdR or left uninfected at 42 h p.i. and
their transcriptome was sequenced by RNA-Seq. (A) Number of significantly regulated genes (padj < 0.05 in DESeq2 analysis) when comparing cell subsets from
Eystrup-infected animals and PdR-infected animals to their counterparts from uninfected animals or comparing subsets between Eystrup- and PdR-infected animals.
(B) Significantly modulated expression of chemokine and cytokine receptor genes displayed as log2 fold change between Eystrup-infected (solid columns) or
PdR-infected (dashed columns) and control animals. (C) Significantly modulated expression of genes related to antigen presentation and apoptosis. DESeq2 analysis
* padj < 0.05, ** padj < 0.001, *** padj < 0.0001. Red-colored asterisks indicate statistical significance (Padj < 0.05) between Eystrup- and PdR-infected animals for
the same cell subset.
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in LN of Eystrup-infected animals, with a downregulation of
CCR2 and an upregulation of CCR7. This CCR7 upregulation
was also found in cDC1 and cDC2 subsets of PdR-infected
animals. Conventional DC type 2 from all infected animals and
pDC from PdR-infected animals displayed an upregulation of
CXCR5, suggesting an ability to migrate to the parafollicular
regions of the lymph nodes.
The cDC2 and pDC subsets also increased their expression of
IL2RA (CD25), which is involved in the interaction with T cells.
We found an increased expression of IL7R, IL23R (both strains)
and IL21R (Eystrup only) by cDC1 and cDC2 subsets, while pDC
downregulated IL7R (Eystrup) and upregulated IL21R following
infection (both CSFV strains; Figure 6B).
The activation of the cDC1 and cDC2 subsets was also
confirmed by the upregulation of costimulatory molecules CD40,
CD83, CD86, TNFRSF9 (CD137L) and TNFSRF11A (RANK),
with the exception ofCD40 for cDC1, andCD86 andTNFRSF11A
for cDC2 in PdR-infected animals (Figure 6C). Interestingly,
some costimulatory molecules were regulated in a more subset-
specific manner. Expression of CD80 was increased only in
cDC1 from Eystrup-infected animals (also significant against
expression by cDC1 from PdR-infected animals), and TNFRSF4
(OX40) was upregulated only by cDC2 with both strains
(Figure 6C). Plasmacytoid DC displayed an increase in CD83,
TNFRSF11A and CD40, the latter only in PdR-infected animals.
At the same time, DC subsets also increased their expression
of co-inhibitory molecules such as CD200 and CD274 (PD-L1).
However, this upregulation of co-inhibitory molecules may not
be a specific effect of CSFV infection, as it was also observed for
all DC subsets following in vitro TLR stimulation.
All subsets isolated from Eystrup-infected animals also
showed a decrease in the expression of class II transactivator
CIITA (Figure 6C). The protein encoded by this gene negatively
regulates MHC class II expression following activation of
DC (42), a mechanism that would prevent processing and
presentation of newly acquired antigens during and following
migration from the site of infection to the lymph nodes.
Expression of the death receptor FAS was exclusively induced
in all subsets isolated from Eystrup-infected animals, whereas
TNFSF10 (TRAIL) was induced in all subsets irrespective of the
virus strain.
In both infected groups, all three DC subsets strongly
upregulated lymphocyte-recruiting chemokines including
CXCL9, CXCL10, and CXCL11 (Figure 7A). However, cDC1
and cDC2 were the only subsets to significantly upregulate
the neutrophil attracting CXCL8 and the eosinophil attracting
CCL11 chemokine genes. Interestingly, the virus infection also
promoted the expression of XCL1, a chemokine specifically
attracting cDC1 (2).
Similar to our in vitro results, pDC and cDC1 were the
only subsets significantly upregulating IL12B. However, while
pDC produced high levels of this mRNA after infection with
both CSFV strains, cDC1 seemed to respond only to the highly
virulent Eystrup strain (Figure 7A). The gene encoding T-cell
homeostatic cytokine IL-7 (IL7) was induced in cDC1, cDC2, and
monocytic cells after infection with Eystrup, but only in cDC2
with PdR. The gene encoding IL-27 (IL27), a cytokine regulating
T-cell responses, was induced in all subsets, irrespective of the
CSFV strain. Gene transcription for the B-cell activating cytokine
BAFF (TNFSF13B) was also increased in all subsets (Figure 7A).
As expected, pDC were clearly the main—and in most
cases the only—subset upregulating type I interferon genes
(Figure 7B). Although higher mean counts for all IFN
type I genes were found with Eystrup when compared
to PdR, this difference was not statistically significant
at the single-gene level (Figure 7B). Conventional DC
type 1 isolated from animals infected with the Eystrup
strain also significantly upregulated IFN-ALPHA-13, IFN-
ALPHAOMEGA, and IFNB1. Type I IFN expression was
associated with the upregulation of many interferon-stimulated
genes (ISG) by all subsets (Figure 7C), among them the
anti-viral genes OASL, OAS2, IFIT1, IFIT2, MX1, and
MX2. This strong induction of IFN-responsive genes also
included certain PRR genes known to be responsive to IFN,
including DHX58 (LGP2), IFIH1 (MDA5) and DDX58 (RIG-I)
(Supplementary Figure 4A). Interestingly, DDX60, encoding a
positive regulator of RIG-I- and MDA5-dependent IFN type I
responses (43), was also highly upregulated by the two viruses
(Supplementary Figure 4A).
As visible in Supplementary Figure 4B, cDC1 and cDC2 were
the only subsets to show an increase in expression of genes
related to the NFκB pathway such as NFKB1 (only Eystrup
for cDC1 and cDC2), NFKB2 (only Eystrup for cDC2), REL
(only Eystrup for cDC1 and cDC2) and RELB (only Eystrup
for cDC2). Genes related to the JAK/STAT pathway were also
upregulated in cDC1 (JAK1 and JAK2 in the Eystrup group) and
cDC2 (JAK1 in the Eystrup group) and in all subsets for the
different STAT genes (Supplementary Figure 4B). Genes related
to TLR signaling were significantly regulated with an increase in
IRAK2 and IRAK4 expression in the monocytic cell subset from
the Eystrup group, while IRAK1 was downregulated in cDC2
from both infected groups and in pDC from the PdR group
(Supplementary Figure 4C). Both cDC subsets also upregulated
TRAF1, TRAF2 (only in Eystrup animals) and TRAF4 (except
for cDC1 from PdR-infected animals). Transcription of TRAF6
was found to be exclusively upregulated in cDC2 from Eystrup-
infected animals.
Modular Analyses of DC Responses After
Virus Infection
To further investigate possible differences in DC/monocytic cell
responses between the two strains of CSFV, we applied GSEA
to the data set of the sorted LN DC using 86 selected gene sets
that were derived from the blood transcription modules (BTM)
described by Li et al. (25) and modified for pigs by Matthijs et al.
(26). The expression of modules containing IFN-α/β genes was
clearly higher in pDC of the Eystrup-infected animals (Figure 8).
Along the same line, we found higher scores for modules
containing interferon responsive genes in the monocytic cells
of Eystrup-infected animals. In contrast, we found a significant
enrichment of some modules related to antigen presentation
such as M5.0 and M95.0 in all DC subsets from the PdR-
infected pigs when compared to the Eystrup group. Furthermore,
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FIGURE 7 | Transcription profiles of LN mononuclear phagocytes after infection with the highly virulent (Eystrup) or the low virulent (PdR) strain of CSFV. cDC1, cDC2,
pDC, and CD14high populations were isolated from mandibular and retropharyngeal LN of animals infected with either Eystrup, PdR or left uninfected at 42 h p.i. and
their transcriptome was sequenced by RNA-Seq. Expression is displayed as log2-fold change between Eystrup-infected (solid columns) or PdR-infected (dashed
columns) and control animals. (A) Significantly modulated expression of chemokine and cytokine genes. (B) Significantly modulated expression of type I IFN genes.
(C) Expression of selected interferon-stimulated genes. DESeq2 analysis * padj < 0.05, ** padj < 0.001, *** padj < 0.0001. red-colored asterisks indicate statistical
significance (padj < 0.05) between Eystrup- and PdR-infected animals for the same subset.
many modules associated with cell cycle were also enriched
in cDC1, pDC and monocytes derived from PdR-infected
animals. In conclusion, these analyses revealed CSFV-strain-
dependent differences in the activation of antigen presenting cells
in the LN.
DISCUSSION
With the unique role of DC at the interface of innate
and adaptive immunity and their ability to induce and
regulate adaptive immune responses, the precise mapping
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FIGURE 8 | Gene-set enrichment analysis of sorted DC and monocytic cells from lymph nodes using 86 selected gene sets that were derived from the BTM
described by Li et al. (25). The normalized enrichment scores (NES) for all modules with a FDR<0.05 are shown.
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of DC responses to immunostimulants or infection is of
importance for the development of improved vaccines and
novel immunotherapeutic strategies. To rationally and efficiently
achieve this for the pig, the identification and characterization
of porcine DC and monocytic cell subsets and their innate
response profiles is crucial. We utilized two complementary ways
of studying DC subset responses: (i) direct in vitro stimulation
of sorted porcine blood DC subsets with defined TLR ligands to
assess the stand-alone transcriptional response of each subset,
and (ii) the transcriptional response of sorted subsets isolated
from lymphoid tissue early after in vivo viral infection.
First of all, we compared the response of DC subsets and
monocytes to the TLR1/2 ligand PAM3Cys which is able to
activate both porcine DC and monocytes (3). When considering
the number of differentially expressed genes, cDC1 and cDC2
were highly responsive to this ligand, while monocytes, despite
the highest expression of TLR1 and TLR2, had the lowest
response. All DC subsets displayed an activated profile with
downregulation of CCR2, and upregulation of CCR7 and
costimulatory molecules, while only cDC1 and cDC2 subsets
upregulated the expression of a broader range of chemokine
receptors targeting both T cells and innate immune cells.
Despite low expression levels of TLR2, pDC were still responsive
to PAM3Cys, but the number of significant differentially
regulated genes was lower than following TLR3, TLR7, or TLR9
stimulation, the three most highly expressed TLRs in porcine
pDC. The present work also confirms the previous observation
(3) that porcine blood pDC are an important source of TNF
following TLR stimulation, and also upregulate a broad range
of type I IFN as well as both IL12A and IL12B following CpG
ODN stimulation. Furthermore, pDC were shown to upregulate
transcription of XCL1, encoding a chemokine that attracts cDC1.
Altogether, this supports the idea that pDC have a central role for
Th1 responses in the pig.
In a parallel approach, we compared the effects of TLR1/2,
TLR3, TLR7, TLR7/8, and TLR9 ligands on pDC with the aim to
determine ligand-specific transcriptional signatures and the most
potent ligand for porcine pDC.While all ligands induced a switch
in chemokine receptors required for migration to lymphoid
tissue, and induced co-stimulatory molecules, only CpG ODN
appeared to induce a “full-blown” IFN type I response, as well
as the transcription of IL12 genes. This indicates that CpG ODN
would be a particularly suitable ligand to target porcine pDC for
induction of potent antiviral and Th1 responses. Furthermore,
resiquimod was found to be very potent in the upregulation
of inflammatory cytokines and chemokines as well as in the
induction of T-cell recruiting chemokines.
In order to study responses of porcine DC in lymphoid tissues,
our next aim was to establish a suitable antibody staining panel
for DC populations in tonsils and lymph nodes. After extensive
phenotyping, we found that both in blood and in lymphoid tissue
cDC1 can be defined as CD14−CD172a−/lowCADM1+,
cDC2 as CD14−CD172a+CADM1+ and pDC as
CD14−CD172a+CADM1−CD4+. In lymphoid tissue, cDC1
expressed the highest levels of CD205 and wCD11R1, cDC2
expressed CD1 and low levels of CSF1R, and pDC expressed
the IL-3 receptor CD123. The identification of these subsets was
confirmed by transcriptomic analyses. As in the blood, only DC
subsets expressed the cross-species pan-DC marker FLT3. DC
subset-specific markers found across species include BATF3,
XCR1, ANPEP (CD13), DPP4 (CD26) for cDC1, FCER1A for
cDC2, and TCF4 (E2-2) and RUNX2 for pDC. We also found
that the expression of IRF4 and IRF8 in porcine DC subsets
isolated from lymph nodes and tonsils matched the pattern
found in porcine blood DC and in DC of other mammalian
species (44–47), with pDC expressing the highest levels of both,
cDC1 expressing more IRF8 than cDC2, and cDC2 expressing
more IRF4 than cDC1. Another study described DC subsets in
the porcine tonsil using a different gating strategy, involving
also class II MHC expression, and found similar subset-specific
transcription patterns of FLT3, TCF4, XCR1, and CSF1R, with
the noticeable exception of IRF4 which was not found to be
expressed in porcine pDC isolated from tonsils (48). The
transcription of TLR genes in porcine DC from lymphoid tissue
was also found to be comparable to the transcription in porcine
DC subsets from blood (3), in particular the pDC-restricted
expression of TLR3. Another peculiarity of porcine pDC was
found to be shared between blood and lymphoid tissue: the high
expression of complement-related genes such asC2,C3, or CD93.
Interestingly, CD93 was shown to be involved in delivery of CpG
ODN to endosomal TLR9 (49) and could be an interesting way of
targeting and activating porcine pDC. Both porcine cDC subsets
from lymphoid tissues also showed expression of markers that
were not expressed on their blood counterparts. As observed in
mouse (32, 45), porcine cDC1 from tonsils and lymph nodes
expressed the gene for CD103 (ITGAE), a specific phenotypic
feature of migratory and tissue cDC1. Porcine lymphoid tissue
cDC2 expressed high levels of FSCN1, a gene associated with
DC migration to lymph nodes (35), and PLA2G2D, a gene
expressed by DC in lymphoid organs (36). Furthermore, similar
to what has been described in porcine lungs (50) and in human
tonsils and lymph nodes (51, 52), porcine lymphoid tissue cDC2
expressed CD207.
The present study also identified a monocytic cell subset
in porcine lymph nodes and tonsils characterized by high
levels of CD14 expression, which clustered with monocytes
and monocyte-derived macrophages in PCA, and expressed
the monocyte/macrophage-specific lineage markers CD64 (53),
CD68 (54) and SLC11A1 (55). The expression of ZFP36L1,
which is selectively upregulated during monocyte/macrophage
differentiation (56), and the macrophage-specific transcription
factors TFEC (57) and MAFB (58), together with CHIT1, a gene
involved in monocyte-to-macrophage differentiation (59), would
indicate that this CD14high population corresponds to monocyte-
derived macrophages.
This precise and unambiguous identification of the DC
subsets in lymphoid tissue allowed us to address the final aim,
which was the early DC response following CSFV infection.
Based on published work (10), we isolated DC subsets from
tonsils at 18 h p.i. However, we could not observe any
differences in gene expression when comparing uninfected
with CSFV-infected animals, suggesting that tonsils might have
been harvested too early following infection. However, we
observed many transcriptional changes in DC subsets from
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mandibular and retropharyngeal lymph nodes at 42 h p.i.
At this later time point, both cDC subsets displayed more
changes in gene transcription following infection with the highly
virulent Eystrup strain than with the low-virulent PdR strain.
Nevertheless, the observed expression profiles of immune-related
genes were overall very similar between both CSFV strains.
Interestingly, pDC isolated from PdR-infected animals displayed
more differentially regulated genes than pDC isolated from
Eystrup-infected animals. The observed differences might reflect
exhaustion of pDC during infection with the highly virulent
strain. On the other hand, it should be pointed out that the PdR
strain has a unique poly-uridine sequence of the 3′UTR, which
possibly promotes pDC activation (8, 60).
An interesting observation was that co-stimulatory molecules
targeting resting T cells, including CD80 and CD86, were
not markedly induced, while inhibitory/regulatory receptors
including LGALS9 (Galectin-9),CD200 andCD274 (PD-L1) were
strongly induced in all DC subsets. Although this upregulation
was also observed following TLR ligand stimulation in vitro,
future studies are required to address if this DC activation profile
could be responsible for the early defects in adaptive immune
responses that are typical for CSFV (9). As previously observed in
the blood of CSFV-infected pigs (61), we observed a prominent
increase in the gene expression of the apoptosis-inducing
death receptor TRAIL by all DC subsets, which, together
with the strong expression of T-cell attracting chemokines,
could contribute to the lymphopenia observed following CSFV
infection. For both the inhibitory and the death receptors,
we often observed higher levels with the virulent strain of
CSFV, which would support a possible pathogenic role of
these responses.
Very high serum levels of type I IFNs are characteristic
for the acute phase of CSF. Our study indeed supports a
central role of pDC in this response, as demonstrated by
the upregulation of many type I IFN genes in pDC from
both, Eystrup and PdR-infected animals. Previous work has
shown that less virulent strains of CSFV resulted in less
IFN-α in the serum of infected animals compared to highly
virulent strains (12, 61, 62). Although we did not observe
significant differences in type I IFN expression at the level
of individual IFN type I genes, GSEA analyses with modules
composed of these genes demonstrated higher IFN responses in
pDC from Eystrup-infected animals. These gene-set enrichment
analyses also demonstrated that modules related to antigen
presentation and cell cycle were more strongly upregulated
following infection with the PdR strain when compared to the
Eystrup strain. For future investigations, we therefore propose
to address the general role of a proliferative DC response
during an acute virus infection, as well as the question if
the observed differences in DC activation could be partly
responsible for the differences in pathogenicity between the two
CSFV strains.
The in vivo data is also relevant to understand the functional
specialization of DC subsets in the pig. In addition to the unique
ability to express IFN type I genes, IL12B transcription was
upregulated by pDC from all infected animals and by cDC1
from Eystrup-infected animals, confirming our in vitro data
and identifying porcine pDC as an important source of this
Th1-promoting cytokine. Another indication for subset-specific
functions is the observation that CXCR5 expression was induced
in cDC2 but not in cDC1, which could reflect the increased
ability of cDC2 to migrate to the parafollicular regions of the
lymph node.
From a methodological point of view, it should be
mentioned that in vitro stimulation of sorted subsets can give
valuable information on how defined subsets can be directly
activated in an isolated context, and is suitable to screen for
immunostimulants. Nevertheless, the data obtained cannot fully
reflect the more complex in vivo situation in which DC activation
is influenced by cell interactions and soluble factors in tissues and
in the local immunological environment. However, during an in
vivo infection, the timing for the interaction of the stimulus or
pathogen with the immune cell is difficult to control. Indeed, we
observed some differences in innate responses of DC subsets in
vivo. For example, CCR7 upregulation was restricted to cDC in
the lymph nodes after in vivo infection, but was observed in vitro
in blood pDC irrespective of the TLR ligand used for stimulation.
The lack of in vivo activated CCR7+ pDC suggests that—at this
stage of infection—only cDC migrate from infection sites to the
lymph nodes. Type and cellular origin of expressed chemokines
also differed when in vivo and in vitro data was compared, again
highlighting the multitude of factors influencing DC activation
in vivo.
Taken together, the data presented here will help
to understand the response of antigen-presenting cells
during infection and will help to target DC for the
development of efficient immunotherapeutic interventions
and vaccine strategies.
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